Ata Mahmoodpoor, Elyad Ekrami, & Hassan Soleimanpour. (2020). Dexmedetomidine: An All Sedation-in-One Drug in Critically Ill Patients with COVID-19. Tabriz University of Medical Sciences.
Chicago Style (17th ed.) CitationAta Mahmoodpoor, Elyad Ekrami, and Hassan Soleimanpour. Dexmedetomidine: An All Sedation-in-One Drug in Critically Ill Patients with COVID-19. Tabriz University of Medical Sciences, 2020.
MLA (9th ed.) CitationAta Mahmoodpoor, et al. Dexmedetomidine: An All Sedation-in-One Drug in Critically Ill Patients with COVID-19. Tabriz University of Medical Sciences, 2020.
Warning: These citations may not always be 100% accurate.